Evidence map›Paper›PMID 36974517›Full record

ArticleProtein science : a publication of the Protein Society2023

SUMO1 hinders α-Synuclein fibrillation by inducing structural compaction.

Rajlaxmi Panigrahi, Rakesh Krishnan, Jai Shankar Singh, Ranjith Padinhateeri, Ashutosh Kumar

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Posttranslational Modifications ofPharmacological reviews · 2024
    Review
  6. Review
  7. SUMO1 hinders α-Synuclein fibrillation by inducing structural compaction.Protein science : a publication of the Protein Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rajlaxmi PanigrahiDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Mumbai, Maharashtra, India.
Rakesh KrishnanDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Mumbai, Maharashtra, India.
Jai Shankar SinghDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Mumbai, Maharashtra, India.
Ranjith PadinhateeriDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Mumbai, Maharashtra, India.
Ashutosh KumarDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Mumbai, Maharashtra, India.ORCID 0000-0002-5061-8162
Indian Institute of Technology Bombay · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small Ubiquitin-like Modifier 1 (SUMO1) is an essential protein for many cellular functions, including regulation, signaling, etc., achieved by a process known as SUMOylation, which involves covalent attachment of SUMO1 to target proteins. SUMO1 also regulates the function of several proteins via non-covalent interactions involving the hydrophobic patch in the target protein identified as SUMO Binding or Interacting Motif (SBM/SIM). Here, we demonstrate a crucial functional potential of SUMO1 mediated by its non-covalent interactions with α-Synuclein, a protein responsible for many neurodegenerative diseases called α-Synucleinopathies. SUMO1 hinders the fibrillation of α-Synuclein, an intrinsically disordered protein (IDP) that undergoes a transition to β-structures during the fibrillation process. Using a plethora of biophysical techniques, we show that SUMO1 transiently binds to the N-terminus region of α-Synuclein non-covalently and causes structural compaction, which hinders the self-association process and thereby delays the fibrillation process. On the one hand, this study demonstrates an essential functional role of SUMO1 protein concerning neurodegeneration; it also illustrates the commonly stated mechanism that IDPs carry out multiple functions by structural adaptation to suit specific target proteins, on the other. Residue-level details about the SUMO1-α-Synuclein interaction obtained here also serve as a reliable approach for investigating the detailed mechanisms of IDP functions.

Indexed as

alpha-SynucleinProtein Bindingalpha-Synucleinaggregationintrinsically disordered proteinsnon-covalent interactionsmall ubiquitin-like modifiersSUMO1transient interactionsα-Synucleinα-Synucleinopathies

Identifiers

PMID36974517
PMCPMC10108436
OpenAlexW4361190288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.